Internalizing RGD (iRGD)-modified liposomal nanoparticles as a universal antigen-delivering platform for remodeling tumors and enhancing T-cell receptor-engineered T cell immunotherapy

Colloids and Surfaces B: Biointerfaces · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles